National Comprehensive Cancer Network

NCCN Research & Business Resources

2014 Archived News

• Four Researchers Awarded Grants to Investigate Effectiveness of Nintedanib* in Lung, Colorectal, and Gastrointestinal Cancers  (09/24/2014)
• Six Organizations Receive Grants from NCCN and Pfizer for Health Care Quality Improvement Programs in Rare Cancers  (06/06/2014)
• NCCN Foundation^® Awards Grants to Five Young Investigators  (05/29/2014)
• NCCN Receives $2 Million in Research Funding from Boehringer Ingelheim to Study Volasertib* in Hematologic Malignancies  (05/22/2014)
• NCCN Receives $2.2 Million in Research Funding from Astellas and Medivation to Study Enzalutamide in Solid Tumors  (04/01/2014)
• NCCN Receives $2 Million in Research Funding from Boehringer Ingelheim to Study Nintedanib* in Colorectal and Lung Cancers  (03/21/2014)
• NCCN Affiliate Research Consortium Offers Community Cancer Centers Cutting-Edge Research Opportunities  (02/06/2014)

For questions about NCCN or for interview information, please contact Jennifer Tredwell 215.690.0274.